Infectious Diseases 1508 - Infectious Disease Alert - Aug 01, 2011

Target Audience:

This activity is intended for the infectious disease specialist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Editor
Stan Deresinski, MD, FACP, FIDSA
Clinical Professor of Medicine
Stanford University
Associate Chief of Infectious Diseases
Santa Clara Valley Medical Center

Board Member and Updates Author
Carol A. Kemper, MD, FACP
Clinical Associate Professor of Medicine
Stanford University
Division of Infectious Diseases
Santa Clara Valley Medical Center

Board Member and Peer Reviewer
Timothy Jenkins, MD
Assistant Professor of Medicine
University of Colorado
Denver Health Medical Center

Associate Editors
Jessica C. Song, MA, PharmD
Assistant Professor, Pharmacy Practice
University of the Pacific, Stockton, CA
Pharmacy Clerkship and Coordinator
Santa Clara Valley Medical Center

Dean L. Winslow, MD, FACP, FIDSA
Chief, Division of AIDS Medicine
Santa Clara Valley Medical Center
Clinical Professor
Stanford University School of Medicine

Brian G. Blackburn, MD
Clinical Assistant Professor of Medicine
Division of Infectious Diseases and Geographic Medicine
Stanford University School of Medicine

Alan D. Tice, MD, FACP
Infectious Disease Consultants
John A. Burns School of Medicine
University of Hawaii
Honolulu

Subjects:

  • Colistimethate: Risk of Serious or Fatal Medication Error
  • Anti-staphylococcal β-lactam Antibiotics Potentiate Daptomycin Activity vs. MRSA
  • Cephalosporin-resistant Gonorrhea: It's Just a Matter of Time
  • Plasma β-glucan for the Diagnosis of Pneumocystis Pneumonia in AIDS Patients
  • How Many Days of Ceftriaxone Is Enough for Meningitis?
  • The AMA and the Infectious Diseases Specialist: House of Delegates Update
  • Updates

Objectives:

  • discuss the diagnosis and treatment of infectious diseases
  • explain current data regarding the use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
  • discuss the latest information regarding risks, benefits and cost-effectiveness of new and traditional diagnostic tests
  • discuss new information regarding how infectious diseases are transmitted and how such information can lead to the development of new therapies

Financial Disclosure:

Infectious Disease Alert's Editor, Stan Deresinski, MD, FACP, FIDSA, does research for the National Institutes of Health, and is an advisory board member and consultant for Merck. Updates Author Carol A. Kemper, MD, FACP, does research for Abbott Laboratories, and Merck. Peer Reviewer Timothy Jenkins, MD, Associate Editors Jessica C. Song, MA, PharmD, Brian G. Blackburn, MD, and Alan D. Tice, MD, FACP, report no financial relationship relavent to this field of study. Associate Editor Dean L. Winslow, MD, FACP, FIDSA, is a speaker for GSK, and is a consultant for Siemens Diagnostics.

Copyright 2011 AHC Media. All rights reserved.